Manish Thakur

Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data

Manish Thakur, Julie J. Ruterbusch, Ann G. Schwartz et al. · Journal of Thoracic Oncology · 2017 · 111 citations · Full text

Second Lung Cancer, Epidemiology, Cancer Risk +11

What Makes a Kinase Promiscuous for Inhibitors?

Sonya M. Hanson, George P. Georghiou, Manish Thakur et al. · Cell chemical biology · 2019 · 105 citations · Full text

Inhibitory Activity, Signal Transduction, Medicine +8

A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders

Aimo Kannt, Sridharan Rajagopal, Sanjay Venkatachalapathi Kadnur et al. · Scientific Reports · 2018 · 96 citations · Full text

Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance

Dhivya Sridaran, Surbhi Chouhan, Kiran Mahajan et al. · Nature Communications · 2022 · 56 citations · Full text

A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study

Manish Thakur, Lance K. Heilbrun, Shijie Sheng et al. · Investigational New Drugs · 2015 · 53 citations

Urology, Phase Ii Trial, Genitourinary Cancer +9